1-(1,3-oxazol-2-ylmethyl)-1H-indazol-5-amine → N,N-dimethyl-2-[4-[[1-(1,3-oxazol-2-ylmethyl)indazol-5-yl]amino]quinazolin-5-yl]oxypropanamide
반응식
[CH3:1][N:2]([C:3]([CH:4]([CH3:5])[O:6][c:7]1[c:8]2[c:9](=[O:17])[nH:10][cH:11][n:12][c:13]2[cH:14][cH:15][cH:16]1)=[O:18])[CH3:19].[o:20]1[c:21]([CH2:25][n:26]2[n:27][cH:28][c:29]3[cH:30][c:31]([NH2:35])[cH:32][cH:33][c:34]23)[n:22][cH:23][cH:24]1>>[CH3:1][N:2]([C:3]([CH:4]([CH3:5])[O:6][c:7]1[c:8]2[c:9]([NH:35][c:31]3[cH:30][c:29]4[cH:28][n:27][n:26]([CH2:25][c:21]5[o:20][cH:24][cH:23][n:22]5)[c:34]4[cH:33][cH:32]3)[n:10][cH:11][n:12][c:13]2[cH:14][cH:15][cH:16]1)=[O:18])[CH3:19]참가 물질
3
출처 및 근거
- ORD 기록
- ord-336e78c1904a4920afaa12ca2da689b1
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (5/10)
반응 노트
불러오는 중…